These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27164899)

  • 1. Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.
    Madsen PH; Holdgaard PC; Christensen JB; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2084-97. PubMed ID: 27164899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Brain Metastases on Follow-up
    Nia ES; Garland LL; Eshghi N; Nia BB; Avery RJ; Kuo PH
    J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
    Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review.
    Groheux D; Quere G; Blanc E; Lemarignier C; Vercellino L; de Margerie-Mellon C; Merlet P; Querellou S
    Diagn Interv Imaging; 2016 Oct; 97(10):1003-1017. PubMed ID: 27567555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of
    Delgado Bolton RC; Calapaquí-Terán AK; Giammarile F; Rubello D
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(4):229-233. PubMed ID: 31202725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.
    Ruilong Z; Daohai X; Li G; Xiaohong W; Chunjie W; Lei T
    Nucl Med Commun; 2017 Jan; 38(1):67-75. PubMed ID: 27741214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Body
    Lebech AM; Gaardsting A; Loft A; Graff J; Markova E; Bertelsen AK; Madsen JL; Andersen KF; Benzon EV; Helms M; Mathiesen LR; David KP; Kronborg G; Kjaer A
    J Nucl Med; 2017 Jul; 58(7):1058-1064. PubMed ID: 28082437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting Pulmonary Nodules in Lung Cancer Patients Using Whole Body FDG PET/CT, High-resolution Lung Reformat of FDG PET/CT, or Diagnostic Breath Hold Chest CT.
    Flavell RR; Behr SC; Mabray MC; Hernandez-Pampaloni M; Naeger DM
    Acad Radiol; 2016 Sep; 23(9):1123-9. PubMed ID: 27283073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
    Pattenden HA; Leung M; Beddow E; Dusmet M; Nicholson AG; Shackcloth M; Mohamed S; Darr A; Naidu B; Iyer S; Marchbank A; Greenwood A; West D; Granato F; Kirk A; Ariyaratnam P; Loubani M; Lim E;
    Thorax; 2015 Apr; 70(4):379-81. PubMed ID: 25124060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LUCIS: lung cancer imaging studies.
    Harders SW
    Dan Med J; 2012 Nov; 59(11):B4542. PubMed ID: 23171752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].
    Weber WA; Dietlein M; Hellwig D; Kirsch CM; Schicha H; Schwaiger M
    Nuklearmedizin; 2003 Aug; 42(4):135-44. PubMed ID: 12937692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
    Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
    Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.
    Chang MC; Chen JH; Liang JA; Lin CC; Yang KT; Cheng KY; Yeh JJ; Kao CH
    Acad Radiol; 2012 Mar; 19(3):349-57. PubMed ID: 22173321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
    Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
    Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.